245 related articles for article (PubMed ID: 32770464)
1. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
[TBL] [Abstract][Full Text] [Related]
2. [Clinical observation of isolated immunoglobulin G4-related sclerosing cholangitis and immunoglobulin G4 sclerosing cholangitis combined autoimmune pancreatitis].
Jiang P; Lian M; Li B; Xiao X; Miao Q; Wang QX; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):415-419. PubMed ID: 30317753
[No Abstract] [Full Text] [Related]
3. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
Tanaka A
Gut Liver; 2019 May; 13(3):300-307. PubMed ID: 30205418
[TBL] [Abstract][Full Text] [Related]
4. [Paying attention to the diagnosis and treatment of IgG4-related sclerosing cholangitis].
Li BL; Xiao JC
Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):508-512. PubMed ID: 31269612
[TBL] [Abstract][Full Text] [Related]
5. IgG4-Related Sclerosing Cholangitis.
Nakazawa T; Shimizu S; Naitoh I
Semin Liver Dis; 2016 Aug; 36(3):216-28. PubMed ID: 27466792
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the long-term outcomes between proximal and distal IgG4-related sclerosing cholangitis: A multicenter cohort study.
Cho SH; Song TJ; Park JS; Yoon JH; Yang MJ; Yoon SB; Lee JM; Lee YN; Kim SH; Choi EK; Park SW; Oh D; Park DH; Lee SS; Seo DW; Lee SK; Kim MH
J Gastroenterol Hepatol; 2023 Apr; 38(4):648-655. PubMed ID: 36710432
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
[TBL] [Abstract][Full Text] [Related]
8. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA).
Park JK; Kim D; Lee JM; Lee KH; Lee KT; Park JK; Lee JK
J Pers Med; 2022 May; 12(6):. PubMed ID: 35743640
[TBL] [Abstract][Full Text] [Related]
10. A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
Radford-Smith DE; Selvaraj EA; Peters R; Orrell M; Bolon J; Anthony DC; Pavlides M; Lynch K; Geremia A; Bailey A; Culver EL; Probert F
Liver Int; 2022 Jun; 42(6):1344-1354. PubMed ID: 35129255
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G4-related sclerosing cholangitis.
Tanaka A
J Dig Dis; 2019 Jul; 20(7):357-362. PubMed ID: 31112324
[TBL] [Abstract][Full Text] [Related]
12. Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity.
Martínez-Valle F; Riveiro-Barciela M; Salcedo MT; Merino-Casabiel X; Fernández-Codina A; Torres I; Esteban R; Buti M
Ann Hepatol; 2019; 18(1):215-219. PubMed ID: 31113593
[TBL] [Abstract][Full Text] [Related]
13. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis.
Itoi T; Kamisawa T; Igarashi Y; Kawakami H; Yasuda I; Itokawa F; Kishimoto Y; Kuwatani M; Doi S; Hara S; Moriyasu F; Baron TH
J Gastroenterol; 2013 Apr; 48(4):504-14. PubMed ID: 22948487
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G4-related hepatobiliary disease.
Lee HE; Zhang L
Semin Diagn Pathol; 2019 Nov; 36(6):423-433. PubMed ID: 31358425
[TBL] [Abstract][Full Text] [Related]
15. Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: Based on a Japanese nationwide study.
Kubota K; Kamisawa T; Nakazawa T; Tanaka A; Naitoh I; Kurita Y; Takikawa H; Unno M; Kawa S; Masamune A; Nakamura S; Okazaki K;
J Gastroenterol Hepatol; 2023 Apr; 38(4):556-564. PubMed ID: 36403136
[TBL] [Abstract][Full Text] [Related]
16. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.
Koyabu M; Uchida K; Miyoshi H; Sakaguchi Y; Fukui T; Ikeda H; Takaoka M; Hirohara J; Nishio A; Uemura Y; Uemoto S; Okazaki K
J Gastroenterol; 2010 Jul; 45(7):732-41. PubMed ID: 20087609
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis.
Smolka V; Karaskova E; Tkachyk O; Aiglova K; Ehrmann J; Michalkova K; Konecny M; Volejnikova J
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):412-8. PubMed ID: 27498582
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification.
Nakazawa T; Naitoh I; Hayashi K; Okumura F; Miyabe K; Yoshida M; Yamashita H; Ohara H; Joh T
J Gastroenterol; 2012 Jan; 47(1):79-87. PubMed ID: 21947649
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
20. IgG4-related sclerosing cholangitis- A great mimicker.
Nayak HK; Bhat SJ; Panigrahi MK; Chouhan I; Kumar C; Samal SC
Indian J Gastroenterol; 2020 Dec; 39(6):614-618. PubMed ID: 33156480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
